Assignee
ANGES MG INC
JP·19 granted patents·19 pending applications·158 citations·filing 2000–2016
Top patents by PatentIndex Score
38 records- 0186US7345158B2Actin related cytoskeletal protein “LACS”ANGES MG INC·Filed 2003·Granted Mar 18, 2008·63 cites·4 claims
- 0284US7285540B2Medicament comprising HGF geneANGES MG INC·Filed 2003·Granted Oct 23, 2007·20 cites·4 claims
- 0384US6913923B2Virus envelope vector for gene transferANGES MG INC·Filed 2001·Granted Jul 5, 2005·16 cites·7 claims
- 0480US7803621B2Virus envelope vector for gene transferANGES MG INC·Filed 2005·Granted Sep 28, 2010·3 cites·17 claims
- 0576US7279333B2Virus envelope vector for gene transferANGES MG INC·Filed 2004·Granted Oct 9, 2007·6 cites·11 claims
- 0676US6989374B1Gene therapy for cardiomyopathyANGES MG INC·Filed 2000·Granted Jan 24, 2006·11 cites·4 claims
- 0775US7994151B2Compositions and methods for angiogenic therapy utilizing genes encoding ets-1ANGES MG INC·Filed 2009·Granted Aug 9, 2011·1 cites·12 claims
- 0875US7247620B2Method of treating skin wounds with vectors encoding hepatocyte growth factorANGES MG INC·Filed 2002·Granted Jul 24, 2007·6 cites·7 claims
- 0974US7595301B2Staple type oligonucleotide and drug comprising the sameANGES MG INC·Filed 2004·Granted Sep 29, 2009·12 cites·3 claims
- 1074US6936594B1Gene therapy for cerebrovascular disordersANGES MG INC·Filed 2000·Granted Aug 30, 2005·8 cites·5 claims
- 1173US7504098B2Method for introducing a biological molecule using a viral envelope and heparin and system thereforeANGES MG INC·Filed 2005·Granted Mar 17, 2009·2 cites·2 claims
- 1271US7871983B2Remedy and preventive for diseases caused by NF-κBANGES MG INC·Filed 2003·Granted Jan 18, 2011·2 cites·14 claims
- 1371US7524830B2Decoy-containing pharmaceutical compositions and method of using the sameANGES MG INC·Filed 2006·Granted Apr 28, 2009·1 cites·3 claims
- 1470US7763591B2Hepatocyte growth factor gene therapy for parkinson's diseaseANGES MG INC·Filed 2002·Granted Jul 27, 2010·4 cites·12 claims
- 1568US2011160132A1Lymphangiogenesis-promoting agentsANGES MG INC·Filed 2006·Application pending·0 cites
- 1667US7939504B2Method of treating skin ulcers with vectors encoding hepatocyte growth factorANGES MG INC·Filed 2007·Granted May 10, 2011·0 cites·7 claims
- 1763US7390482B2Drug for auditory dysfunctionANGES MG INC·Filed 2003·Granted Jun 24, 2008·1 cites·2 claims
- 1862US7259149B2Methods for treating or preventing angiogenesis-dependent symptomsANGES MG INC·Filed 2003·Granted Aug 21, 2007·2 cites·4 claims
- 1960US9889186B2Oral vaccine having improved cellular immunity induction potencyANGES MG INC·Filed 2014·Granted Feb 13, 2018·0 cites·16 claims
- 2060US2009004260A1Medicament comprising hgf geneANGES MG INC·Filed 2008·Application pending·0 cites
- 2157US2011045061A1Gene therapy for diabetic ischemic diseaseANGES MG INC·Filed 2010·Application pending·0 cites
- 2257US2009105183A1Pharmaceutical composition containing decoy and method of using the sameANGES MG INC·Filed 2008·Application pending·0 cites
- 2356US2016271219A1Lymphangiogenesis-promoting agentsANGES MG INC·Filed 2016·Application pending·0 cites
- 2456US2008213348A1Agents for gene therapy of cerebrovascular disordersANGES MG INC·Filed 2008·Application pending·0 cites
- 2556US2006116344A1Remedy and preventive for diseases caused by NF-kBANGES MG INC·Filed 2006·Application pending·0 cites
- 2654US2006263422A1Pharmaceutical composition containing decoy and use of the sameANGES MG INC·Filed 2006·Application pending·0 cites
- 2754US2008207552A1Decoy compositions for treating and preventing brain diseases and disordersANGES MG INC·Filed 2007·Application pending·0 cites
- 2852US2009215868A1Therapeutic Medicament for Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, and Pulmonary HypertensionANGES MG INC·Filed 2006·Application pending·0 cites
- 2951US2008312145A1Agent for Regulating Bone FormationANGES MG INC·Filed 2005·Application pending·0 cites
- 3050US2006234969A1Compositions and methods for inhibiting inflammation of vessel walls and formation of neointimal hyperplasiaANGES MG INC·Filed 2004·Application pending·0 cites
- 3148US2016250290A1Gene therapy for diabetic ischemic diseaseANGES MG INC·Filed 2015·Application pending·0 cites
- 3244US2004087535A1Pharmaceutical composition for angiogenesisANGES MG INC·Filed 2003·Application pending·0 cites
- 3344US2010311823A1Agent for regulating bone formationANGES MG INC·Filed 2010·Application pending·0 cites
- 3444US2005080140A1Method for treating or preventing inflammatory disordersANGES MG INC·Filed 2004·Application pending·0 cites
- 3542US2006233815A1Agents for protection from neointimal formation in grafts comprising an nfkappab decoyANGES MG INC·Filed 2002·Application pending·0 cites
- 3640US2009082263A1Drug and method for improving brain functionANGES MG INC·Filed 2005·Application pending·0 cites
- 3738US2006134078A1Method for culturing neural stem cells using hepatocyte growth factorANGES MG INC·Filed 2003·Application pending·0 cites
- 3834US7790692B2Hepatocyte growth factor nucleic acid sequence to enhance musculocutaneous flap survivalANGES MG INC·Filed 2005·Granted Sep 7, 2010·0 cites·12 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →